IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells

Molecular Endocrinology

Volumn 25, Issue 9, 2011, Pages 1636-1649

  Radhakrishnan, Yashwanth ^a   Shen, Xinchun ^a   Maile, Laura A ^a   Xi, Gang ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEOME; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME PHOSPHORYLATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AMINO ACID SUBSTITUTION; ANIMALS; GENE SILENCING; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RECEPTOR, IGF TYPE 1; RECEPTORS, IMMUNOLOGIC; SUS SCROFA;

EID: 80052280239     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-0035     Document Type: Article

References (44)

1. Arnqvist HJ, Bornfeldt KE, Chen Y, Lindström T 1995 The insulinlike growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 44:58-66.
2. Joslin E, Kahn CR 2005 Joslin's diabetes mellitus. 14th ed. Boston: Lippincott Williams, Wilkins
3. Radhakrishnan Y, Busby Jr WH, Shen X, Maile LA, Clemmons DR 2010 Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells. J Biol Chem 285:15682-15695.
4. Shen X, Xi G, Radhakrishnan Y, ClemmonsDR2009 Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells. Mol Cell Proteomics 8:1539-1551
5. Ling Y, Maile LA, Lieskovska J, Badley-Clarke J, Clemmons DR 2005 Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Mol Biol Cell 16:3353-3364.
6. Maile LA, Capps BE, Miller EC, Allen LB, Veluvolu U, Aday AW, Clemmons DR 2008 Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. Mol Endocrinol 22:1226-1237.
7. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR 2007 Hyperglycemia alters the responsiveness of smooth muscle cells to insulinlike growth factor-I. Endocrinology 148:2435-2443.
8. Radhakrishnan Y, Maile LA, Ling Y, Graves LM, Clemmons DR 2008 Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J Biol Chem 283:16320-16331.
9. Elbaz N, Bedecs K, Masson M, Sutren M, Strosberg AD, Nahmias C 2000 Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Mol Endocrinol 14: 795-804.
10. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A 1997 A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181-186.
11. Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T, Kasuga M 1996 A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 16:6887-6899.
12. Stofega MR, Wang H, Ullrich A, Carter-Su C 1998 Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J Biol Chem 273:7112-7117.
13. Mitsuhashi H, Futai E, Sasagawa N, Hayashi Y, Nishino I, Ishiura S 2008 Csk-homologous kinase interacts with SHPS-1 and enhances neurite outgrowth of PC12 cells. J Neurochem 105:101-112.
14. Chong YP, Mulhern TD, Zhu HJ, Fujita DJ, Bjorge JD, Tantiongco JP, Sotirellis N, Lio DS, Scholz G, Cheng HC 2004 A novel noncatalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity. J Biol Chem 279:20752-20766.
15. Klages S, Adam D, Class K, Fargnoli J, Bolen JB, Penhallow RC 1994 Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family. Proc Natl Acad Sci USA 91:2597-2601.
16. Kuo SS, Moran P, Gripp J, Armanini M, Phillips HS, Goddard A, Caras IW 1994 Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk. J Neurosci Res 38:705-715.
17. Bennett BD, Cowley S, Jiang S, London R, Deng B, Grabarek J, Groopman JE, Goeddel DV, Avraham H 1994 Identification and characterization of a novel tyrosine kinase from megakaryocytes. J Biol Chem 269:1068-1074.
18. McVicar DW, Lal BK, Lloyd A, Kawamura M, Chen YQ, Zhang X, Staples JE, Ortaldo JR, O'Shea JJ 1994 Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes. Oncogene 9:2037-2044.
19. Sakano S, Iwama A, Inazawa J, Ariyama T, Ohno M, Suda T 1994 Molecular cloning of a novel non-receptor tyrosine kinase, HYL (hematopoietic consensus tyrosine-lacking kinase). Oncogene 9:1155-1161.
20. Kim S, Zagozdzon R, Meisler A, Baleja JD, Fu Y, Avraham S, Avraham H 2002 Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer. J Biol Chem 277:36465-36470.
21. Kuo SS, Armanini MP, Phillips HS, Caras IW 1997 Csk and BatK show opposite temporal expression in the rat CNS: consistent with its late expression in development, BatK induces differentiation of PC12 cells. Eur J Neurosci 9:2383-2393.
22. Yamashita H, Avraham S, Jiang S, Dikic I, Avraham H 1999 The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells. J Biol Chem 274:15059-15065.
23. Price DJ, Rivnay B, Fu Y, Jiang S, Avraham S, Avraham H 1997 Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes. J Biol Chem 272:5915-5920.
24. Maile LA, Capps BE, Miller EC, Aday AW, Clemmons DR 2008 Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates IGF-I signaling in vivo. Diabetes 57:2637-2643.
25. Lieskovska J, Ling Y, Badley-Clarke J, Clemmons DR 2006 The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 281:25041-25053.
26. Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, Zhu F, Ma WY, Sham Y, Rogozin EA, Bode AM, Cao Y, Dong Z 2007 Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev 16:598-605.
27. Shemer J, Adamo M, Raizada MK, Heffez D, Zick Y, LeRoith D 1989 Insulin and IGF-I stimulate phosphorylation of their respective receptors in intact neuronal and glial cells in primary culture. J Mol Neurosci 1:3-8.
28. Maile LA, Clemmons DR 2002 Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J Biol Chem 277:8955-8960.
29. Maile LA, Badley-Clarke J, Clemmons DR 2003 The association between integrin-associated protein and SHPS-1 regulates insulinlike growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14:3519-3528.
30. Chisalita SI, Johansson GS, Liefvendahl E, Bäck K, Arnqvist HJ 2009 Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. J Mol Endocrinol 43:231-239.
31. Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G 2005 Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. J Biol Chem 280:25780-25787.
32. Mikkola ET, Bergman M 2003 Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK. FEBS Lett 544:11-14.
33. Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O 2004 The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/ Akt apoptotic pathway. Oncogene 23:7854-7862.
34. Jernberg-Wiklund H, Nilsson K 2007 Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). Adv Cancer Res 97:139-165.
35. Levinson NM, Visperas PR, Kuriyan J 2009 The tyrosine kinase Csk dimerizes through its SH3 domain. PLoS One 4:e7683
36. Chong YP, Mulhern TD, Cheng HC 2005 C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK) endogenous negative regulators of Src-family protein kinases. Growth Factors 23:233-244.
37. Chong YP, Chan AS, Chan KC, Williamson NA, Lerner EC, Smithgall TE, Bjorge JD, Fujita DJ, Purcell AW, Scholz G, Mulhern TD, Cheng HC 2006 C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases. J Biol Chem 281:32988-32999.
38. Takada T, Matozaki T, Takeda H, Fukunaga K, Noguchi T, Fujioka Y, Okazaki I, Tsuda M, Yamao T, Ochi F, Kasuga M 1998 Roles of the complex formation of SHPS-1 with SHP-2 in insulinstimulated mitogen-activated protein kinase activation. J Biol Chem 273:9234-9242.
39. Zagozdzon R, Kaminski R, Fu Y, Fu W, Bougeret C, Avraham HK 2006 Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner. Cell Signal 18:871-881
40. Zagozdzon R, Bougeret C, Fu Y, Avraham HK 2002 Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells. Int J Oncol 21:1347-1352.
41. Blakesley VA, Kato H, Roberts Jr CT, LeRoithD1995 Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function. J Biol Chem 270:2764-2769.
42. Buckley DA, Cheng A, Kiely PA, Tremblay ML, O'Connor R 2002 Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol 22:1998-2010.
43. Nam TJ, Busby Jr WH, Rees C, Clemmons DR 2000 Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology 141:1100-1106.
44. Jones JI, Prevette T, Gockerman A, Clemmons DR 1996 Ligand occupancy of the α-V-β3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487